IMpower132: A phase III clinical program-1L atezolizumab plus platinum-based chemotherapy in chemo-naive advanced non-squamous NSCLC.

Overview

cited authors

West, Howard Jack; Nishio, Makoto; Dols, Manuel Cobo; Saito, Haruhiro; Howland, Michael; Hoang, Tien; Asakawa, Takashi; Sandler, Alan; Socinski, Mark A.

authors

Socinski, Mark A., MD

Publication Date

May 20, 2017

webpage

Web of Science

published in

JOURNAL OF CLINICAL ONCOLOGY Journal

301 E Princeton St., Orlando, FL 32804 | FH.RAS@AdventHealth.com | 407-200-2901

The information on this website is not a substitute for examination, diagnosis, and medical care provided by a licensed and qualified health professional. Please consult your physician before undertaking any form of medical treatment and/or adopting any exercise program or dietary guidelines. If you think you may have a medical emergency, call your physician or 911 immediately. AdventHealth Research Institute reserves the right to add, remove or edit content on this page at its sole discretion.